HomeCompareTARO vs JEPI

TARO vs JEPI: Dividend Comparison 2026

TARO yields 4.65% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPI wins by $8.5K in total portfolio value
10 years
TARO
TARO
● Live price
4.65%
Share price
$42.98
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$0.47
Full TARO calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — TARO vs JEPI

📍 JEPI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTAROJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TARO + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TARO pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TARO
Annual income on $10K today (after 15% tax)
$395.58/yr
After 10yr DRIP, annual income (after tax)
$0.40/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, JEPI beats the other by $1,298.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TARO + JEPI for your $10,000?

TARO: 50%JEPI: 50%
100% JEPI50/50100% TARO
Portfolio after 10yr
$24.7K
Annual income
$764.55/yr
Blended yield
3.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TARO right now

TARO
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
3.5
Piotroski
7/9
JEPI
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TARO buys
0
JEPI buys
0
No recent congressional trades found for TARO or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTAROJEPI
Forward yield4.65%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$20.5K$29.0K
Annual income after 10y$0.47$1,528.62
Total dividends collected$472.00$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: TARO vs JEPI ($10,000, DRIP)

YearTARO PortfolioTARO Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$10,933$232.69$11,260$840.19$327.00JEPI
2$11,817$118.88$12,641$907.94$824.00JEPI
3$12,704$60.04$14,150$978.20$1.4KJEPI
4$13,624$30.16$15,795$1,050.85$2.2KJEPI
5$14,592$15.12$17,584$1,125.74$3.0KJEPI
6$15,621$7.57$19,526$1,202.74$3.9KJEPI
7$16,719$3.78$21,628$1,281.69$4.9KJEPI
8$17,891$1.89$23,898$1,362.43$6.0KJEPI
9$19,144$0.95$26,347$1,444.79$7.2KJEPI
10$20,485$0.47$28,982$1,528.62$8.5KJEPI

TARO vs JEPI: Complete Analysis 2026

TAROStock

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Full TARO Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this TARO vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TARO vs SCHDTARO vs OTARO vs KOTARO vs MAINTARO vs JEPQTARO vs XYLDTARO vs DIVOTARO vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.